Rare Cancers | NFCR Blog

Rare cancers are those that affect fewer than 40,000 people per year in the U.S.* For multiple reasons, there is a gap in research support for rare cancers, which can limit research progress. Learn more about NFCR’s genomic approach which aims to benefit ALL types of cancers.

Genetic Cues to Ovarian Cancer Explored

September is Ovarian Cancer Awareness Month, highlighting a disease that kills nearly…

Read more

New Combination Therapy Improves Pancreatic Cancer Survival

A new combination of two standing drugs and radiation therapy has the…

Read more

Origin Cells of Glioblastoma May Have Been Identified

In what could be a major breakthrough, scientists at the Korea Advanced…

Read more

Esophageal Cancer Awareness Month: Identifying Potential for New, Personalized Treatments

Although esophageal cancer makes up only 1% of cancer diagnoses in the…

Read more

Trending Improvements for Multiple Myeloma

While it may not be an extremely common cancer, multiple myeloma, awareness…

Read more

“Pink Drink” to Aid Brain Tumor Treatment

Approved in June 2017 by the U.S. Food and Drug Administration and…

Read more

November Is Pancreatic Cancer Awareness Month

Even in the company of other vicious diseases, pancreatic cancer is particularly…

Read more

The Development of Better Ovarian Cancer Biomarkers

Mark It Down “The trouble with ultrasound is that it doesn’t detect…

Read more

Exercise for Sarcoma Patients

Exercise and stretching are important for everyone and at all times. They…

Read more